Filter News
Area of Research
- (-) Advanced Manufacturing (2)
- (-) Nuclear Science and Technology (8)
- (-) Supercomputing (6)
- Biological Systems (1)
- Biology and Environment (2)
- Clean Energy (13)
- Computational Engineering (1)
- Computer Science (5)
- Fusion Energy (4)
- Materials (19)
- National Security (2)
- Neutron Science (4)
- Quantum information Science (2)
News Topics
- (-) Advanced Reactors (6)
- (-) Bioenergy (2)
- (-) Cybersecurity (2)
- (-) Isotopes (2)
- (-) Space Exploration (4)
- 3-D Printing/Advanced Manufacturing (8)
- Artificial Intelligence (7)
- Big Data (4)
- Biomedical (3)
- Composites (1)
- Computer Science (29)
- Critical Materials (1)
- Energy Storage (1)
- Environment (2)
- Exascale Computing (2)
- Frontier (2)
- Fusion (2)
- Grid (1)
- Materials Science (5)
- Molten Salt (3)
- Nanotechnology (1)
- Neutron Science (2)
- Nuclear Energy (16)
- Physics (2)
- Polymers (1)
- Quantum Science (5)
- Security (1)
- Summit (11)
- Sustainable Energy (2)
- Transportation (2)
Media Contacts
OAK RIDGE, Tenn., Feb. 12, 2019—A team of researchers from the Department of Energy’s Oak Ridge and Los Alamos National Laboratories has partnered with EPB, a Chattanooga utility and telecommunications company, to demonstrate the effectiveness of metro-scale quantum key distribution (QKD).
By automating the production of neptunium oxide-aluminum pellets, Oak Ridge National Laboratory scientists have eliminated a key bottleneck when producing plutonium-238 used by NASA to fuel deep space exploration.
The Department of Energy’s Oak Ridge National Laboratory is collaborating with industry on six new projects focused on advancing commercial nuclear energy technologies that offer potential improvements to current nuclear reactors and move new reactor designs closer to deployment.
A tiny vial of gray powder produced at the Department of Energy’s Oak Ridge National Laboratory is the backbone of a new experiment to study the intense magnetic fields created in nuclear collisions.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.